4 unknown, 3 completed, 1 recruiting. 4 Phase 4, 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Unknown 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow T 614: new trials by email Literature Review of T 614 trials Research Report on T 614
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Clinical Efficacy of Immunomodulators in RA Patients Iguratimod, Methotrexate, Adalimumab Injection - Arthritis, Rheumatoid | Phase 4 | Recruiting | Qilu Hospital of Shandong University | 400 | 2021-12-22 | 2022-11-29 |
| The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA Iguratimod, Tofacitinib, Pred - Arthritis, Rheumatoid | Phase 4 | Completed | Qilu Hospital of Shandong University | 100 | 2020-03-01 | 2023-11-18 |
| The Iguratimod Effect on Lupus Nephritis (IGeLU) Iguratimod, Cyclophosphamide, Azathioprine - Lupus Nephritis | Phase 2 | Unknown | RenJi Hospital | 120 | 2017-09-07 | 2018-12-19 |
| To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom T 614 - IgG4-related Disease | Phase 4 | Unknown | Wen Zhang | 30 | 2017-09-01 | 2018-04-11 |
| Iguratimod as Treatment for Refractory Lupus Nephritis Iguratimod - Lupus Nephritis | Not applicable | Unknown | RenJi Hospital | 30 | 2017-05-08 | 2017-02-27 |
| Study of Iguratimod in Sjögren's Syndrome Iguratimod - Sjogren's Syndrome | Phase 1 / Phase 2 | Unknown | Peking Union Medical College Hospital | 30 | 2017-02-01 | 2017-01-18 |
| The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment Iguratimod, MTX, HCQ - Arthritis, Rheumatoid | Phase 4 | Completed | Qilu Hospital of Shandong University | 400 | 2016-01-01 | 2023-11-18 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate T-614, Placebo - Rheumatoid Arthritis | Phase 3 | Completed | Eisai Co., Ltd. | 253 | 2009-07-31 | 2021-12-17 |
Arthritis, Rheumatoid (4) · Lupus Nephritis (2) · Immunoglobulin G4-Related Disease (1) · Nephritis (1) · Sjogren's Syndrome (1)
Qilu Hospital of Shandong University (3) · RenJi Hospital (2) · Eisai Co., Ltd. (1) · Peking Union Medical College Hospital (1) · Wen Zhang (1)
China (7) · Japan (1)
Chunde Bao, MD (1) · Kota Nagai (1) · Ming Lv, Dr. (1) · Wen Zhang (1) · Xiaoyun Yang (1) · Xiaoyun Yang, Dr. (1) · Yan Zhao, Dr. (1)